Waitlist and Transplant Outcomes in Organ Donation After Circulatory Death: Trends in the United States

Jennie H Kwon1, Walker M Blanding1, Khaled Shorbaji1

  • 1Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC.

Annals of Surgery
|June 19, 2023
PubMed

Insights

Organ donation after circulatory death (DCD) improves transplant access and waitlist outcomes for liver and heart patients. While DCD kidney, liver, and lung transplants show increased mortality, survival remains acceptable.

Area of Science:

  • Transplantation Medicine
  • Organ Donation
  • Public Health

Background:

  • Organ donation after circulatory death (DCD) has expanded the donor pool for solid organ transplantation.
  • DCD is increasingly utilized, particularly in heart transplantation.

Purpose of the Study:

  • To evaluate waitlist and transplant outcomes for kidney, liver, lung, and heart transplantation using DCD.
  • Compare outcomes between DCD and donation after brain death (DBD) for various organs.

Main Methods:

  • Utilized the United Network for Organ Sharing registry for adult transplant candidates and recipients.
  • Employed propensity matching and competing-risks regression for waitlist outcomes.
  • Applied propensity matching, Kaplan-Meier, and Cox regression for survival analysis.

Main Results:

  • DCD transplant volumes have significantly increased across all organs.
  • Liver candidates for DCD organs had higher transplant rates; heart and liver candidates had reduced waitlist deterioration.
  • DCD kidney, liver, and lung recipients showed increased mortality risk up to 5 years post-transplant compared to DBD, with no difference in 1-year heart transplant mortality.

Conclusions:

  • DCD expands transplantation access and improves waitlist outcomes for liver and heart candidates.
  • Despite increased mortality risks in DCD kidney, liver, and lung transplantation, overall survival is considered acceptable.
  • DCD is a valuable strategy for increasing organ availability and improving patient outcomes in transplantation.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
417
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
37
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
41